Studies using MCF-7 and SK-BR breast carcinoma cells showed that NRF2 significantly increased the proliferation activity and progression activity of both carcinoma cells and suggested that NRF2 acts as a prognostic factor in breast cancer patients [7]. This evidence concerns the gene NFE2L2 and carcinoma.